San Antonio — Medical device maker Cardiovate has closed a $1 million seed round of funding from an existing group of investors to help it
San Antonio — An early stage San Antonio startup that aims to repair or replace clogged arteries with regenerated tissue has closed a small financing round from angel investors, The University of Texas Horizon Fund, and Targeted Technology, according to its CEO.
May 31, 2016 This material is available primarily for archival purposes. Telephone numbers or other contact information may be out of date; please see current
Two San Antonio-based bioscience companies — StemBioSys Inc. and Cardiovate Inc. — have agreed to work in tandem on new stem cell research that could
Much of the activity in San Antonio’s technology sector this year could be dominated by companies involved in biomedical technologies, Texas Research and Technology Foundation
San Antonio-based biotech startup Cardiovate has signed a patent and technology licensing agreement with the University of Texas at San Antonio and the University of Texas Health Science Center San Antonio.
12500 Network Blvd Suite 310
San Antonio, Texas 78249
Research & Development
2500 Crosspark Rd. E-141 Coralville, IA 52241
© Copyright 2017 Cardiovate, Inc. All Rights Reserved.